Langat D K, Mwenda J M
Institute of Primate Research, National Museums of Kenya, Karen, Nairobi.
Acta Trop. 2000 Sep 18;76(2):147-58. doi: 10.1016/s0001-706x(00)00075-9.
The shortage of cadaveric human organs for transplantation may, be alleviated by the use of xenografts as a therapeutic option for end-stage organ failure. Successful attempts have been made to prevent rejection of xenograft tissues in humans. The potential spread of animal-derived pathogens to the xenograft recipient is a complication of xenotransplantation, which must be addressed. This can be complicated further by, the presence of new pathogens, new clinical syndromes, and altered behaviour of these organisms in the immunocompromised recipient. There is concern over the possible activation of latent viruses, including retroviruses, from xenograft tissues. This paper discusses the possible dangers of transmission of animal viruses to humans via xenotransplantation.
通过使用异种移植物作为终末期器官衰竭的治疗选择,可缓解人体移植用尸体器官的短缺问题。在预防人体异种移植组织排斥方面已取得成功尝试。动物源性病原体向异种移植受者的潜在传播是异种移植的一个并发症,必须加以解决。新病原体的存在、新的临床综合征以及这些生物体在免疫功能低下受者体内行为的改变,可能会使情况进一步复杂化。人们担心异种移植组织中潜伏病毒(包括逆转录病毒)可能被激活。本文讨论了动物病毒通过异种移植传播给人类的潜在危险。